Dawn E. Post
Impact in
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
- Internal Medicine top 5%
Papers in ⓘ
-
- Viral Infectious Diseases and Gene Expression in Insects 3
- Genetics 9
- Virus-based gene therapy research 9
- Co-authors
- Erwin G. Van Meir (10 shared papers)Jonathan W. Simons (2 shared papers)Fadlo R. Khuri (2 shared papers)Hua Zhong (2 shared papers)Daniel J. Brat (3 shared papers)Balveen Kaur (2 shared papers)Nicola J. Mabjeesh (1 shared paper)Margaret Willard (1 shared paper)
- Journals
- Clinical Cancer Research (2 papers)Gene Therapy (2 papers)Cancer Research (2 papers)Human Gene Therapy (1 paper)Investigational New Drugs (1 paper)
- Partner nations
- United StatesCanadaSingapore
In The Last Decade
Dawn E. Post
17 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 72
- Cancer Research 387
- Internal Medicine 73
- Biotechnology 155
- Genetics 499
- Oncology 348
Countries citing papers authored by Dawn E. Post
This map shows the geographic impact of Dawn E. Post's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dawn E. Post with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dawn E. Post more than expected).
Fields of papers citing papers by Dawn E. Post
This network shows the impact of papers produced by Dawn E. Post. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dawn E. Post. The network helps show where Dawn E. Post may publish in the future.
Co-authors
The 25 scholars most cited alongside Dawn E. Post, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Geldanamycin induces degradation of hypoxia-inducible factor 1alpha protein via the proteosome pathway in prostate cancer cells. | 2002 | 253 |
| 2 | 2005 | 190 | |
| 3 | 2004 | 133 | |
| 4 | 2003 | 106 | |
| 5 | 2007 | 90 | |
| 6 | 2004 | 87 | |
| 7 | 2003 | 62 | |
| 8 | 2004 | 50 | |
| 9 | 2004 | 50 | |
| 10 | 2013 | 38 | |
| 11 | 2019 | 32 | |
| 12 | 2010 | 27 | |
| 13 | 2017 | 16 | |
| 14 | 2010 | 14 | |
| 15 | 2005 | 12 | |
| 16 | 2011 | 8 | |
| 17 | 2019 | 1 | |
| 18 | 2026 | 0 |
About Dawn E. Post
Dawn E. Post is a scholar working on Molecular Biology, Genetics, Oncology, Biotechnology and Cancer Research, having authored 18 papers that have together received 1.2k indexed citations. Recurring topics across this work include Virus-based gene therapy research (9 papers), Cancer, Hypoxia, and Metabolism (5 papers), Cancer Research and Treatments (5 papers), CAR-T cell therapy research (4 papers), Viral Infectious Diseases and Gene Expression in Insects (3 papers), Prostate Cancer Treatment and Research (2 papers), Herpesvirus Infections and Treatments (2 papers) and Neuroblastoma Research and Treatments (1 paper). The work is most often cited by research in Cancer Research (387 citations), Internal Medicine (73 citations), Biotechnology (155 citations), Genetics (499 citations) and Oncology (348 citations). Dawn E. Post has collaborated with scholars based in United States, Canada and Singapore. Frequent co-authors include Erwin G. Van Meir, Jonathan W. Simons, Fadlo R. Khuri, Hua Zhong, Daniel J. Brat, Balveen Kaur, Nicola J. Mabjeesh, Margaret Willard, Roland Chu and Yuan Rong. Their work appears in journals such as Clinical Cancer Research, Gene Therapy, Cancer Research, Human Gene Therapy and Investigational New Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.